<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>582</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15501393</PubmedId>
            <Abstract>Autoantibodies against DFS70 (Dense Fine Speckles 70) are found in 30% of Japanese atopic dermatitis patients, and less frequently in patients with other diseases. We have recently reported that they are also seen in 11% of hospital workers, but in only approximately 2% of patients with systemic rheumatic disease. In this study, in order to investigate the possible pathological role of anti-DFS70 antibodies, fine epitope mapping was carried out using 93 anti-DFS70 autoantibody-positive sera. Immunoblotting using overlapping peptides failed to reveal major linear epitopes. Western blotting using various truncated proteins showed a strikingly uniform epitope distribution on a suspected tertiary structure expressed by DFS70(349-435). Some sera showed reactivity only in an immunoprecipitation assay using an in vitro translated DFS70. Circular dichroism analysis revealed that DFS(349-435) contains an approximately 40% alpha-helical conformation, while an overlapping, non-antigenic peptide is composed of random coiled structures. The skewed single major epitope enabled us to establish a highly quantitative ELISA for the epitope region. Antibody titers showed no significant differences between the diseased group and healthy individuals. We propose that anti-DFS70 antibody may be a natural autoantibody, which might modify or reflect the inflammatory process of various disorders.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>221-31</ArticlePages>
            <ArticleTitle>Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Ogawa</LastName>
                    <ForeName>Yasushi</ForeName>
                </Author>
                <Author>
                    <LastName>Sugiura</LastName>
                    <ForeName>Kazumitsu</ForeName>
                </Author>
                <Author>
                    <LastName>Watanabe</LastName>
                    <ForeName>Akihiro</ForeName>
                </Author>
                <Author>
                    <LastName>Kunimatsu</LastName>
                    <ForeName>Mitoshi</ForeName>
                </Author>
                <Author>
                    <LastName>Mishima</LastName>
                    <ForeName>Masaki</ForeName>
                </Author>
                <Author>
                    <LastName>Tomita</LastName>
                    <ForeName>Yasushi</ForeName>
                </Author>
                <Author>
                    <LastName>Muro</LastName>
                    <ForeName>Yoshinao</ForeName>
                </Author>
            </Authors>
            <Affiliations>Division of Connective Tissue Disease &amp; Autoimmunity, Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.</Affiliations>
            <ArticleChemicalList>Adaptor Proteins, Signal Transducing;Autoantigens;Epitopes;Immune Sera;PSIP1 protein, human;Trans-Activators;Transcription Factors</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adaptor Proteins, Signal Transducing; Adolescent; Adult; Aged; Amino Acid Sequence; Animals; Autoantigens(chemistry; genetics; immunology); Child; Circular Dichroism; Epitope Mapping; Epitopes(chemistry; genetics; immunology); Female; Humans; Immune Sera(immunology); Immunoprecipitation; Male; Middle Aged; Molecular Sequence Data; Mutation(genetics); Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Alignment; Tissue Donors; Trans-Activators(chemistry; genetics; immunology); Transcription Factors</ArticleMeshHeadingsList>
            <Journal>
                <Volume>23</Volume>
                <Issue>3</Issue>
                <Title>Journal of autoimmunity</Title>
                <Issn>0896-8411</Issn>
                <MedlineTa>J Autoimmun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>DFS70 513-527</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SSEERETEISLKDST</LinearSequence>
                        <StartingPosition>513</StartingPosition>
                        <EndingPosition>527</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>O75475.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results</LocationOfData>
                <EpitopeId>60968</EpitopeId>
                <ReferenceStartingPosition>513</ReferenceStartingPosition>
                <ReferenceEndingPosition>527</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This linear determinant was found in rabbit post-immune serum and in the serum of 1 of 59 patients positive for DFS70 antibodies It was determined that the primary autoantibody determinant is alpha-helical, conformation-dependent, and restricted to amino acids 349-435 of DFS70, but specific residues comprising the epitopic determinant(s) were not refined in this publication.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <BCellId>17321</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9986</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SSEERETEISLKDST</LinearSequence>
                                            <StartingPosition>513</StartingPosition>
                                            <EndingPosition>527</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>O75475.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DFS70 513-527</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope mapping of linear determinants was performed via peptide array of 12-mer peptides spanning DFS70 residues 326-527.  In this experiment, the array of peptides was tested against sera of rabbits immunized with the DFS70 C-terminal peptide 513-527. The specific 12-mer peptides that reacted with anti-DFS70 513-527 Ab were shown in the immunoblot but not referenced in the article text.  The blot reflects 12 reactive spots which authors state correspond to the immunizing peptide.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-DFS70 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Overlapping 12-mers with gap length=1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SSEERETEISLKDST</LinearSequence>
                                        <StartingPosition>513</StartingPosition>
                                        <EndingPosition>527</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O75475.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>DFS70 519-526</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TEISLKDS</LinearSequence>
                        <StartingPosition>519</StartingPosition>
                        <EndingPosition>526</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>O75475.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Results</LocationOfData>
                <EpitopeId>63409</EpitopeId>
                <ReferenceStartingPosition>519</ReferenceStartingPosition>
                <ReferenceEndingPosition>526</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This linear determinant is deduced from reactivity of overlapping 12-mers in serum of 1 of 59 patients positive for DFS70 antibodies. It was determined that the primary autoantibody determinant is alpha-helical, conformation-dependent, and restricted to amino acids 349-435 of DFS70, but specific residues comprising the epitopic determinant(s) were not refined in this publication.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1E</LocationOfData>
                        <BCellId>18045</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of allergy</InVivoProcessType>
                                <DiseaseState>DOID:1205</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </FirstInVivoProcess>
                            <ImmunizationComments>59 sera of 670 sera in the serum bank of Nagoya Hospital were judged to be positive for anti-DFS-70 Ab by indirect fluoresence assay and western blotting assay using HeLa nuclear extract.   Clinical diagnoses of the patients from which the sera derived were of a wide variety of allergic diseases.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>59</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>1.7</ResponseFrequency>
                            <AssayComments>Epitope mapping of linear determinants was performed via peptide array of 12-mer peptides spanning DFS70 residues 326-527.  In this experiment, the array of peptides was tested against 59 samples of human sera.  Only 1 of the 59 human sera tested were reactive against the array.  In the one reactive sample, there were total of 5 reactive spots, all corresponding to this C-terminal epitope.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-DFS70 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>DFS70 synthetic 12-mer 515-526</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EERETEISLKDS</LinearSequence>
                                        <StartingPosition>515</StartingPosition>
                                        <EndingPosition>526</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O75475.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1E</LocationOfData>
                        <BCellId>18047</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of allergy</InVivoProcessType>
                                <DiseaseState>DOID:1205</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                            </FirstInVivoProcess>
                            <ImmunizationComments>59 sera of 670 sera in the serum bank of Nagoya Hospital were judged to be positive for anti-DFS-70 Ab by indirect fluoresence assay and western blotting assay using HeLa nuclear extract.   Clinical diagnoses of the patients from which the sera derived were of a wide variety of allergic diseases.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>59</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>1.7</ResponseFrequency>
                            <AssayComments>Epitope mapping of linear determinants was performed via peptide array of 12-mer peptides spanning DFS70 residues 326-527.  In this experiment, the array of peptides was tested against 59 samples of human sera.  Only 1 of the 59 sera tested were reactive against the array.  In the one reactive sample, there were a total of 5 reactive spots, all corresponding to this C-terminal epitope.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-DFS70 Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>DFS70 synthetic 12-mer 519-530</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TEISLKDSTLDN</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>530</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>O75475.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

